BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Duseja A, Das R, Nanda M, Das A, Garewal G, Chawla Y. Nonalcoholic steatohepatitis in Asian Indians is neither associated with iron overload nor with HFE gene mutations. World J Gastroenterol 2005; 11(3): 393-395 [PMID: 15637751 DOI: 10.3748/wjg.v11.i3.393]
URL: https://www.wjgnet.com/2150-5330/full/v11/i3/393.htm
Number Citing Articles
1
Jian-Gao Fan, Seung-Up Kim, Vincent Wai-Sun Wong. New trends on obesity and NAFLD in AsiaJournal of Hepatology 2017; 67(4): 862 doi: 10.1016/j.jhep.2017.06.003
2
Mohd Talha Noor, Manish Tiwari, Ravindra Kumar. Non-HFE iron overload as a surrogate marker of disease severity in patients of liver cirrhosisIndian Journal of Gastroenterology 2016; 35(1): 33 doi: 10.1007/s12664-016-0623-6
3
M. Srinivas, Vijaya Srinivasan, Madhu Bashini Mohan, Joy Varghese, Jayanthi Venkataraman. A study of gender-wise risk association between fatty liver and metabolic syndrome components (Asia-Pacific criteria) in a South Indian urban cohortIndian Journal of Gastroenterology 2015; 34(1): 38 doi: 10.1007/s12664-014-0525-4
4
Abhishek Goyal, Bishav Mohan, Kavita Saggar, Gurpreet Singh Wander. Primary haemochromatosis resulting in dilated cardiomyopathy arising out of mutation in HJV gene in Indian patients: a rare scenarioBMJ Case Reports 2020; 13(9): e235650 doi: 10.1136/bcr-2020-235650
5
Ajay Duseja, Naga Chalasani. Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD)Hepatology International 2013; 7(S2): 755 doi: 10.1007/s12072-013-9480-x
6
P. Nahon, N. Ganne-Carrié, J.-C. Trinchet, M. Beaugrand. Hepatic iron overload and risk of hepatocellular carcinoma in cirrhosisGastroentérologie Clinique et Biologique 2010; 34(1): 1 doi: 10.1016/j.gcb.2009.07.032
7
Shivakumar Chitturi, Geoffrey C Farrell, Etsuko Hashimoto, Toshiji Saibara, George KK Lau, José D Sollano. Non‐alcoholic fatty liver disease in the Asia–Pacific region: Definitions and overview of proposed guidelinesJournal of Gastroenterology and Hepatology 2007; 22(6): 778 doi: 10.1111/j.1440-1746.2007.05001.x
8
Ajay Duseja. Nonalcoholic fatty liver disease in India – a lot done, yet more required!Indian Journal of Gastroenterology 2010; 29(6): 217 doi: 10.1007/s12664-010-0069-1
9
Yoshio Sumida, Toshikazu Yoshikawa, Takeshi Okanoue. Role of hepatic iron in non‐alcoholic steatohepatitisHepatology Research 2009; 39(3): 213 doi: 10.1111/j.1872-034X.2008.00442.x
10
Antonello Pietrangelo, Michael Torbenson. Macsween's Pathology of the Liver2018; : 275 doi: 10.1016/B978-0-7020-6697-9.00004-2
11
Naoki Fujita, Yoshiyuki Takei. Advances in Clinical Chemistry 2011; 55: 105 doi: 10.1016/B978-0-12-387042-1.00006-X
12
Halis Simsek, Yasemin H. Balaban, Hale Sümer, Engin Yılmaz, Gonca Tatar. HFE Mutations Analysis of Turkish Patients with Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2006; 51(10): 1723 doi: 10.1007/s10620-006-9114-4
13
MARIANA MACHADO, HELENA CORTEZ‐PINTO. Nash, insulin resistance and ironLiver International 2006; 26(10): 1159 doi: 10.1111/j.1478-3231.2006.01394.x
14
Maha Guindi. Practical Hepatic Pathology: A Diagnostic Approach2011; : 177 doi: 10.1016/B978-0-443-06803-4.00014-9
15
Hye Young Kim, Woo Young Kwon, Joon Beom Park, Mi Hwa Lee, Yoo Jin Oh, SungHwan Suh, Yang Hyun Baek, Jin Sook Jeong, Young Hyun Yoo. Hepatic STAMP2 mediates recombinant FGF21‐induced improvement of hepatic iron overload in nonalcoholic fatty liver diseaseThe FASEB Journal 2020; 34(9): 12354 doi: 10.1096/fj.202000790R
16
Zoon Tariq, Charlotte J. Green, Leanne Hodson. Are oxidative stress mechanisms the common denominator in the progression from hepatic steatosis towards non‐alcoholic steatohepatitis (NASH)?Liver International 2014; 34(7) doi: 10.1111/liv.12523
17
Masato Yoneda, Yuichi Nozaki, Hiroki Endo, Hironori Mawatari, Hiroshi Iida, Koji Fujita, Kyoko Yoneda, Hirokazu Takahashi, Hiroyuki Kirikoshi, Masahiko Inamori, Noritoshi Kobayashi, Kensuke Kubota, Satoru Saito, Shiro Maeyama, Kikuko Hotta, Atsushi Nakajima. Serum Ferritin Is a Clinical Biomarker in Japanese Patients with Nonalcoholic Steatohepatitis (NASH) Independent of HFE Gene MutationDigestive Diseases and Sciences 2010; 55(3): 808 doi: 10.1007/s10620-009-0771-y
18
Reena Das, Giriraj Ratan Chandak. Obscure pathogenesis of primary iron overload in Indians warrants more focused researchIndian Journal of Gastroenterology 2011; 30(4): 154 doi: 10.1007/s12664-011-0119-3
19
James E. Nelson, Heather Klintworth, Kris V. Kowdley. Iron Metabolism in Nonalcoholic Fatty Liver DiseaseCurrent Gastroenterology Reports 2012; 14(1): 8 doi: 10.1007/s11894-011-0234-4
20
Richard Kirsch, Helene P. Sijtsema, Mpho Tlali, Adrian D. Marais, Pauline de la M Hall. Effects of iron overload in a rat nutritional model of non‐alcoholic fatty liver diseaseLiver International 2006; 26(10): 1258 doi: 10.1111/j.1478-3231.2006.01329.x
21
Ajay Duseja, Ashim Das, Reena Das, R. K. Dhiman, Y. Chawla, A. Bhansali, Naveen Kalra. The Clinicopathological Profile of Indian Patients with Nonalcoholic Fatty Liver Disease (NAFLD) is Different from That in the WestDigestive Diseases and Sciences 2007; 52(9): 2368 doi: 10.1007/s10620-006-9136-y
22
Carolin Lackner. Practical Hepatic Pathology: a Diagnostic Approach2018; : 167 doi: 10.1016/B978-0-323-42873-6.00012-3
23
Eleftheria Makri, Myrsini Orfanidou, Evangelia S. Makri, Antonis Goulas, Evangelos Terpos, Stergios A. Polyzos. Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysisJournal of Clinical and Experimental Hepatology 2024; 14(3): 101353 doi: 10.1016/j.jceh.2024.101353
24
Alan C. Paterson, Antonello Pietrangelo. MacSween's Pathology of the Liver2012; : 261 doi: 10.1016/B978-0-7020-3398-8.00005-2
25
Mariana Verdelho Machado, Anna Mae Diehl. Zakim and Boyer's Hepatology2018; : 369 doi: 10.1016/B978-0-323-37591-7.00025-2
26
Swastik Agrawal, Ajay K Duseja. Non-alcoholic Fatty Liver Disease: East Versus WestJournal of Clinical and Experimental Hepatology 2012; 2(2): 122 doi: 10.1016/S0973-6883(12)60101-7
27
Kotacherry T. Shenoy, Leena K. Balakumaran, Philip Mathew, Mohan Prasad, Boddu Prabhakar, Ajit Sood, Shivaram P. Singh, Nagaraj P. Rao, Shoukat A. Zargar, Angelo A. Bignamini. Metadoxine Versus Placebo for the Treatment of Non-alcoholic Steatohepatitis: A Randomized Controlled TrialJournal of Clinical and Experimental Hepatology 2014; 4(2): 94 doi: 10.1016/j.jceh.2014.03.041
28
Maha Guindi. Practical Hepatic Pathology: a Diagnostic Approach2018; : 151 doi: 10.1016/B978-0-323-42873-6.00011-1
29
V. C. S. Srinivasarao Bandaru, Jaydip R. Chaudhury, Palle Lalitha, Somala N. Reddy, Pradeep K. Misra, Banda Balaraju, Kandadai R. Mridula. Prevalence of asymptomatic nonalcoholic fatty liver disease in nondiabetic participants: a study from south indiaThe Egyptian Journal of Internal Medicine 2019; 31(1): 92 doi: 10.4103/ejim.ejim_76_18
30
Hye Young Kim, Young Hyun Yoo. The Role of STAMP2 in Pathogenesis of Chronic Diseases Focusing on Nonalcoholic Fatty Liver Disease: A ReviewBiomedicines 2022; 10(9): 2082 doi: 10.3390/biomedicines10092082
31
Richard Kirsch, Ralph Kirsch. Nutrition, Diet Therapy, and the Liver2009; : 97 doi: 10.1201/9781420085501.ch7
32
Amanda J. Hooper, Leon A. Adams, John R. Burnett. Genetic determinants of hepatic steatosis in manJournal of Lipid Research 2011; 52(4): 593 doi: 10.1194/jlr.R008896
33
Raseen Tariq, Page Axley, Ashwani K. Singal. Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A ReviewJournal of Clinical and Experimental Hepatology 2020; 10(1): 81 doi: 10.1016/j.jceh.2019.07.008
34
Vlad Pădureanu, Dalia Dop, Alice Drăgoescu, Rodica Pădureanu, Anca Mușetescu, Laurențiu Nedelcu. Non‑alcoholic fatty liver disease and hematologic manifestations (Review)Experimental and Therapeutic Medicine 2021; 22(6) doi: 10.3892/etm.2021.10790
35
James E. Nelson, Renuka Bhattacharya, Keith D. Lindor, Naga Chalasani, Stuart Raaka, E. Jenny Heathcote, Emil Miskovsky, Eldon Shaffer, Stephen J. Rulyak, Kris V. Kowdley. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitisHepatology 2007; 46(3): 723 doi: 10.1002/hep.21742
36
Darrell H. G. Crawford, Linda M. Fletcher, Kris V. Kowdley. Iron Physiology and Pathophysiology in Humans2012; : 441 doi: 10.1007/978-1-60327-485-2_22
37
Ajay Duseja, Yogesh Kumar Chawla. Obesity and NAFLDClinics in Liver Disease 2014; 18(1): 59 doi: 10.1016/j.cld.2013.09.002
38
Shweta Kapil, Ajay Duseja, Bal Krishan Sharma, Bhupesh Singla, Anuradha Chakraborti, Ashim Das, Pallab Ray, Radha K Dhiman, Yogesh Chawla. Genetic polymorphism in <i>CD14</i> gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2016; 22(42): 9346-9355 doi: 10.3748/wjg.v22.i42.9346
39
Ajay Duseja, Reena Das, Ashim Das, R. K. Dhiman, Y. K. Chawla, G. Garewal. Serum Iron Levels and Hepatic Iron Overload in Patients with Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2006; 51(10): 1730 doi: 10.1007/s10620-005-9041-9